Registry of Acute Coronary Syndrome From University Hospital of Vigo
NCT ID: NCT03664388
Last Updated: 2018-09-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
8000 participants
OBSERVATIONAL
2016-02-01
2020-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cangrelor in Patients With Acute Myocardial Infarction Undergoing PCI After CPR, Ventilated or Cardiogenic Shock
NCT04611607
The Effect of IV Cangrelor and Oral Ticagrelor Study
NCT02733341
Coronariography in OUt of hosPital Cardiac arrEst
NCT02641626
Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor
NCT02422888
Sub Lingual Versus Traditional Oral Administration of Ticagrelor in Acute Coronary Syndrome/Non ST-elevation Myocardial Infarction - A Platelet Reactivity Study
NCT02402400
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The objective of the project was to study cardiac and bleeding complications, such as reinfarction, heart failure, atrial fibrillation, stroke, and bleeding events, together with all-cause and cardiac mortality
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dual antiplatelet therapy with ticagrelor/prasuglre
Compare bleeding and ischemic events according to the type and duration of dual antiplatelet therapy
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Álvaro Cunqueiro
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emad Abu-Assi, MD, PhD
Role: STUDY_CHAIR
University Hospital Álvaro Cunqueiro, Vigo, Spain
Sergio Raposeiras-Roubín, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital Álvaro Cunqueiro, Vigo, Spain
Andres Iñiguez-Romo, MD, PhD
Role: STUDY_DIRECTOR
University Hospital Álvaro Cunqueiro, Vigo, Spain
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Cardiology, Hospital Álvaro Cunqueiro
Vigo, Pontevedra, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Hospital Alvaro Cunqueiro
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.